Recent advances in amphiphilic polymers for simultaneous delivery of hydrophobic and hydrophilic drugs

Chloe Martin, Noorjahan Aibani, John Callan, Bridgeen Callan

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Nanomedicine has evolved with the use of biological compounds such as proteins, peptides and DNA. These hydrophilic and often highly charged compounds require a delivery system to allow effective transport and release at the site of action. These new biological therapeutics have not replaced the more traditional smaller molecule, but instead are working synergistically to the benefit of the end user. To that end, drug delivery systems are now required to encapsulate both larger hydrophilic compounds as well as the smaller and generally more hydrophobic compound. This review highlights the emerging role in drug delivery of amphiphilic polymers that by theirvery nature can associate with compounds of differing physicochemical properties, inparticular the role of micelles, polymersomes and nanocapsules.
LanguageEnglish
Pages15-31
JournalTherapeutic Delivery
Volume7
Issue number1
Early online date10 Dec 2015
DOIs
Publication statusPublished - Jan 2016

Fingerprint

Nanocapsules
Nanomedicine
Micelles
Drug Delivery Systems
Polymers
Peptides
DNA
Pharmaceutical Preparations
Proteins
Therapeutics

Keywords

  • Amphiphilic polymer
  • Polymeric micelle
  • Polymersome
  • Nanocapsule: Hydrophilic compounds
  • Hydrophobic compounds
  • Simultaneous drug delivery.

Cite this

@article{4e113322865a405f90cf61de4a4c5b9d,
title = "Recent advances in amphiphilic polymers for simultaneous delivery of hydrophobic and hydrophilic drugs",
abstract = "Nanomedicine has evolved with the use of biological compounds such as proteins, peptides and DNA. These hydrophilic and often highly charged compounds require a delivery system to allow effective transport and release at the site of action. These new biological therapeutics have not replaced the more traditional smaller molecule, but instead are working synergistically to the benefit of the end user. To that end, drug delivery systems are now required to encapsulate both larger hydrophilic compounds as well as the smaller and generally more hydrophobic compound. This review highlights the emerging role in drug delivery of amphiphilic polymers that by theirvery nature can associate with compounds of differing physicochemical properties, inparticular the role of micelles, polymersomes and nanocapsules.",
keywords = "Amphiphilic polymer, Polymeric micelle, Polymersome, Nanocapsule: Hydrophilic compounds, Hydrophobic compounds, Simultaneous drug delivery.",
author = "Chloe Martin and Noorjahan Aibani and John Callan and Bridgeen Callan",
year = "2016",
month = "1",
doi = "10.4155/tde.15.84",
language = "English",
volume = "7",
pages = "15--31",
journal = "Therapeutic Delivery",
issn = "2041-5990",
number = "1",

}

Recent advances in amphiphilic polymers for simultaneous delivery of hydrophobic and hydrophilic drugs. / Martin, Chloe; Aibani, Noorjahan; Callan, John; Callan, Bridgeen.

In: Therapeutic Delivery, Vol. 7, No. 1, 01.2016, p. 15-31.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Recent advances in amphiphilic polymers for simultaneous delivery of hydrophobic and hydrophilic drugs

AU - Martin, Chloe

AU - Aibani, Noorjahan

AU - Callan, John

AU - Callan, Bridgeen

PY - 2016/1

Y1 - 2016/1

N2 - Nanomedicine has evolved with the use of biological compounds such as proteins, peptides and DNA. These hydrophilic and often highly charged compounds require a delivery system to allow effective transport and release at the site of action. These new biological therapeutics have not replaced the more traditional smaller molecule, but instead are working synergistically to the benefit of the end user. To that end, drug delivery systems are now required to encapsulate both larger hydrophilic compounds as well as the smaller and generally more hydrophobic compound. This review highlights the emerging role in drug delivery of amphiphilic polymers that by theirvery nature can associate with compounds of differing physicochemical properties, inparticular the role of micelles, polymersomes and nanocapsules.

AB - Nanomedicine has evolved with the use of biological compounds such as proteins, peptides and DNA. These hydrophilic and often highly charged compounds require a delivery system to allow effective transport and release at the site of action. These new biological therapeutics have not replaced the more traditional smaller molecule, but instead are working synergistically to the benefit of the end user. To that end, drug delivery systems are now required to encapsulate both larger hydrophilic compounds as well as the smaller and generally more hydrophobic compound. This review highlights the emerging role in drug delivery of amphiphilic polymers that by theirvery nature can associate with compounds of differing physicochemical properties, inparticular the role of micelles, polymersomes and nanocapsules.

KW - Amphiphilic polymer

KW - Polymeric micelle

KW - Polymersome

KW - Nanocapsule: Hydrophilic compounds

KW - Hydrophobic compounds

KW - Simultaneous drug delivery.

U2 - 10.4155/tde.15.84

DO - 10.4155/tde.15.84

M3 - Article

VL - 7

SP - 15

EP - 31

JO - Therapeutic Delivery

T2 - Therapeutic Delivery

JF - Therapeutic Delivery

SN - 2041-5990

IS - 1

ER -